R A Gibson
Overview
Explore the profile of R A Gibson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
163
Citations
2774
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ikeda N, Shepherd E, Makrides M, McPhee A, Gibson R, Gould J
Prostaglandins Leukot Essent Fatty Acids
. 2024 May;
201:102620.
PMID: 38763084
Objective: This narrative review aimed to summarize studies assessing the effects of parenteral fish oil on neurodevelopment in preterm infants. Methods: PubMed was searched (July 1985 to October 2023). We...
2.
Gould J, Bednarz J, Sullivan T, McPhee A, Gibson R, Makrides M
Prostaglandins Leukot Essent Fatty Acids
. 2023 Nov;
198-199:102593.
PMID: 37979339
A recent trial showed that high-dose docosahexaenoic acid (high-DHA) supplementation of infants born <29 weeks' gestation improves intelligence quotient (IQ) at five years' corrected age. However, this finding has not...
3.
Best K, Gibson R, Makrides M
Prostaglandins Leukot Essent Fatty Acids
. 2022 Oct;
186:102495.
PMID: 36228573
Globally, preterm birth is the leading cause of death in children under the age of 5 years and survivors may suffer life-long consequences. Following many years of investigation, there is...
4.
Gibson R, Makrides M, Sullivan T, Yelland L, Best K
Prostaglandins Leukot Essent Fatty Acids
. 2022 Jun;
182:102454.
PMID: 35688084
No abstract available.
5.
Best K, Gibson R, Yelland L, Leemaqz S, Gomersall J, Liu G, et al.
Prostaglandins Leukot Essent Fatty Acids
. 2020 Oct;
162:102181.
PMID: 33038832
Introduction: Omega-3 long chain polyunsaturated fatty acids (LCPUFA) have been associated with a reduction in risk for preterm birth. However, there is limited understanding of how fatty acids and their...
6.
Simmonds L, Sullivan T, Skubisz M, Middleton P, Best K, Yelland L, et al.
BJOG
. 2020 Feb;
127(8):975-981.
PMID: 32034969
Objective: To identify a polyunsaturated fatty acid (PUFA) biomarker able to detect which women with singleton pregnancies are most likely to benefit from omega-3 supplementation to reduce their risk of...
7.
Vithayathil M, Gugusheff J, Ong Z, Langley-Evans S, Gibson R, Muhlhausler B
Nutr Metab (Lond)
. 2018 Feb;
15:17.
PMID: 29467799
Background: While the adverse metabolic effects of exposure to obesogenic diets during both the prenatal and early postnatal period are well established, the relative impact of exposure during these separate...
8.
van Dijk S, Peters T, Buckley M, Zhou J, Jones P, Gibson R, et al.
Int J Obes (Lond)
. 2017 Oct;
42(1):28-35.
PMID: 29064478
Background/objectives: There is increasing evidence that metabolic diseases originate in early life, and epigenetic changes have been implicated as key drivers of this early life programming. This led to the...
9.
Wood K, Mantzioris E, Lingwood B, Couper J, Makrides M, Gibson R, et al.
Prostaglandins Leukot Essent Fatty Acids
. 2017 Oct;
139:49-54.
PMID: 29032859
Background: Animal studies have suggested that an increased supply of omega-3 long chain polyunsaturated fatty acids (LCPUFA), in particular docosahexaenoic acid (DHA), during the perinatal period can prevent later excess...
10.
Yelland L, Gajewski B, Colombo J, Gibson R, Makrides M, Carlson S
Prostaglandins Leukot Essent Fatty Acids
. 2016 Sep;
112:44-9.
PMID: 27637340
The DHA to Optimize Mother Infant Outcome (DOMInO) and Kansas DHA Outcomes Study (KUDOS) were randomized controlled trials that supplemented mothers with 800 and 600mg DHA/day, respectively, or a placebo...